How Much Did 10X Science Raise?
Funding & Key Investors

10X Science has successfully secured a major strategic investment, marking a pivotal milestone in its trajectory toward transforming the drug discovery landscape. This latest capital injection, totaling $4.8M, underscores the market's confidence in the company's proprietary platform. With a cumulative capital base of $4.8M, the firm is well-positioned to accelerate its enterprise-level operations and solidify its footprint in the competitive biotechnology sector.

What is 10X Science?

10X Science
SoftwareEngineering SoftwareBusiness Services

10X Science operates at the intersection of biotechnology and artificial intelligence, providing a sophisticated platform for protein characterization. By leveraging machine learning to interpret complex biological data, the company addresses critical bottlenecks in early-stage therapeutic development. Its technology replaces manual, error-prone analysis with automated, high-consistency insights, effectively streamlining the evaluation of drug candidates. This market position allows research teams to significantly reduce the time-to-market for novel therapeutics, positioning 10X Science as an essential infrastructure provider for modern biopharma R&D workflows.

How much funding has 10X Science raised?

10X Science has raised a total of $4.8M across 1 funding round:

2026

Seed

$4.8M

Seed (2026): $4.8M with participation from Civilization Ventures, Y Combinator, and Initialized Capital

Key Investors in 10X Science

Civilization Ventures

A venture capital firm specializing in health tech and biopharma, focusing on preventative, personalized, and regenerative healthcare solutions.

Y Combinator

A premier startup accelerator and seed-stage investor providing capital and mentorship to high-growth technology companies.

Initialized Capital

A venture capital firm dedicated to supporting seed-stage founders across diverse sectors including artificial intelligence, enterprise SaaS, and health tech.

What's next for 10X Science?

With this major enterprise-level funding, 10X Science is poised to scale its computational infrastructure and expand its commercial reach. The strategic roadmap likely involves deepening its machine learning capabilities to handle increasingly complex protein datasets while simultaneously scaling its sales and support teams to meet growing demand from global pharmaceutical partners. By focusing on the integration of AI into the core of drug discovery, the company aims to set a new industry standard for efficiency and precision in therapeutic development, ultimately driving long-term value for its stakeholders and the broader healthcare ecosystem.

See full 10X Science company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Security SoftwareSoftwareBusiness ServicesSecurity Information and Event Management (SIEM)
Engineering SoftwareSoftwareFinancial Software
Financial SoftwareSoftware
Software

Frequently Asked Questions Regarding 10X Science Financial Insights

What are the most recent funding rounds that 10X Science has completed, and what were the funding rounds?
10X Science has recently completed 1 funding rounds: Seed on Apr 22, 2026.
What is the total amount of funding 10X Science has raised to date?
10X Science has raised a total of $4.8M in funding to date.
How many funding rounds has 10X Science completed?
10X Science has completed 1 funding rounds.
How much funding did 10X Science raise in its most recent funding round?
10X Science raised $4.8M in its most recent funding round.
Who are the lead investors in 10X Science's latest funding round?
The lead investor in 10X Science's latest funding round was Civilization Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in 10X Science's history?
The largest funding round in 10X Science's history was $4.8M.
See more information about 10X Science